CFAP161 p.Arg226Trp
c.676C>T · VCV4226849
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1819 | likely benign |
|---|---|---|
| REVEL | 0.256 | benign-leaning |
| SaProt | LLR -12.52 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | Δ0.31 | acceptor loss · deltas |
| Constraint at this position | ||
| Conservation | phyloP 5.6 | phastCons 0.95 |
| Regional constraint | o/e 0.99 | unconstrained · MANE · 14 kb · p 0.8 · regional, not allelic |
| Overall | ||
| CADD | 26.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.00908% | 11,019 |
| Remaining individualsnot grpmax-eligible | 0.00801% | 12,483 |
| Admixed American | 0.00335% | 29,835 |
| East Asian | 0.00223% | 44,838 |
| South Asian | 0.0011% | 90,558 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CFAP161
- Protein
- p.Arg226Trp
- Coding
- c.676C>T
- MANE Select
- NM_173528
- Type
- single nucleotide variant
- Location
- chr15:81147897 (GRCh38)
- Gene constraint
- LOEUF 1.029 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 87.29 · 2 PDB
Similar variants
- CFAP161 p.Arg226Gln Uncertain significance ★ ⚠ same residue
- CFAP161 p.Ala115Thr Uncertain significance ★ ⚠ same type
- CFAP161 p.Ala295Ser Uncertain significance ★ ⚠ same type
- CFAP161 p.Ala2Ser Uncertain significance ★ ⚠ same type
- CFAP161 p.Arg203Cys Uncertain significance ★ same type
- CFAP161 p.Arg203His Uncertain significance ★ same type
- CFAP161 p.Arg87His Uncertain significance ★ ⚠ same type
- CFAP161 p.Asn14Lys Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cfap161-p-arg226trp (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown